Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 2,874 | 1,300 | 3,965 | 2,582 | 1,965 |
| Cost of Goods | 141 | 51 | 8 | 59 | 0 |
| Gross Profit | 2,733 | 1,249 | 3,957 | 2,523 | 1,965 |
| Operating Expenses | 9,500 | 26,067 | 5,824 | 5,424 | 4,187 |
| Operating Income | -6,626 | -24,767 | -1,859 | -2,842 | -2,222 |
| Interest Expense | 124 | 36 | 5 | 5 | 6 |
| Other Income | 101 | 46 | -4 | 178 | 469 |
| Pre-tax Income | -6,649 | -24,757 | -1,868 | -2,669 | -1,759 |
| Income Tax | -33 | -715 | -4 | N/A | 0 |
| Net Income Continuous | -6,616 | -24,042 | -1,864 | -2,703 | -1,759 |
| Net Income | $-6,616 | $-24,042 | $-1,864 | $-2,703 | $-1,759 |
| EPS Basic Total Ops | -0.19 | -0.70 | -0.05 | 0.83 | -0.05 |
| EPS Basic Continuous Ops | -0.19 | -0.70 | -0.05 | 0.09 | -0.05 |
| EPS Diluted Total Ops | -0.19 | -0.70 | -0.05 | 0.83 | -0.05 |
| EPS Diluted Continuous Ops | -0.19 | -0.70 | -0.05 | 0.09 | -0.05 |
| EBITDA(a) | $-6,228 | $-24,586 | $-1,794 | $-2,778 | $-2,157 |